I. Ziv

发表

The mystery of motor asymmetry in Parkinson's disease

R. Djaldetti, I. Ziv, E. Melamed, 2006, The Lancet Neurology.

Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease.

R. Djaldetti, I. Ziv, E. Melamed, 1996, Israel journal of medical sciences.

Two Waves of Cyclin B and Proliferating Cell Nuclear Antigen Expression During Dopamine‐Triggered Neuronal Apoptosis

A. Barzilai, I. Ziv, E. Melamed, 1997, Journal of neurochemistry.

Early‐occurrence of manual motor blocks in Parkinson's disease: a quantitative assessment

R. Djaldetti, I. Ziv, E. Melamed, 1999, Acta neurologica Scandinavica.

Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with 18F-ML-10

R. Djaldetti, I. Ziv, A. Allen, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis

I. Ziv, Galit Levin, A. Shirvan, 2009, Apoptosis.

Small-Molecule Biomarkers for Clinical PET Imaging of Apoptosis

A. Akselrod-Ballin, A. Wall, I. Ziv, 2010, Journal of Nuclear Medicine.

Parkinson's disease in a patient with mitochondrial myopathy: Is there a causative relationship?

A. Achiron, R. Djaldetti, I. Ziv, 1992, Movement disorders : official journal of the Movement Disorder Society.

Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.

R. Djaldetti, I. Ziv, E. Melamed, 1999, Journal of neural transmission. Supplementum.

Riluzole for le vodopa-induced dyskinesias in advanced P arkinson's disease

R. Djaldetti, I. Ziv, E. Melamed, 1999, The Lancet.

Molecular imaging of cell death in vivo by a novel small molecule probe

I. Ziv, Galit Levin, A. Shirvan, 2006, Apoptosis.

Prevention of Dopamine-Induced Cell Death by Thiol Antioxidants: Possible Implications for Treatment of Parkinson's Disease

I. Ziv, E. Melamed, D. Offen, 1996, Experimental Neurology.

Dopamine-induced programmed cell death in mouse thymocytes.

A. Barzilai, I. Ziv, E. Melamed, 1995, Biochimica et biophysica acta.

Levodopa Toxicity and Apoptosis

A. Barzilai, R. Djaldetti, I. Ziv, 1998, Annals of neurology.

Enhanced Oxidative Stress and Altered Antioxidants in Brains of Bcl‐2‐Deficient Mice

S. Korsmeyer, I. Ziv, E. Melamed, 1998, Journal of neurochemistry.

Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons — A possible novel pathogenetic mechanism in Parkinson's disease

A. Barzilai, A. Achiron, I. Ziv, 1994, Neuroscience Letters.

Dopamine–melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease

A. Barzilai, I. Ziv, E. Melamed, 1997, Neurochemistry International.

Expression of Cell Cycle-Related Genes During Neuronal Apoptosis: Is there a Distinct Pattern?

A. Barzilai, I. Ziv, E. Melamed, 1998, Neurochemical Research.

Levodopa – an exotoxin or a therapeutic drug?

I. Ziv, E. Melamed, D. Offen, 2000, Journal of Neurology.

Levodopa induces apoptosis in cultured neuronal cells—A possible accelerator of nigrostriatal degeneration in Parkinson's disease?

A. Barzilai, I. Ziv, E. Melamed, 1997, Movement disorders : official journal of the Movement Disorder Society.

The effect of deprenyl washout in patients with long-standing Parkinson's disease

R. Djaldetti, I. Ziv, E. Melamed, 2002, Journal of Neural Transmission.

Dopamine-induced, genotoxic activation of programmed cell death. A role in nigrostriatal neuronal degeneration in Parkinson's disease?

I. Ziv, E. Melamed, A. Achiron, 1996, Advances in neurology.

Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process?

I. Ziv, E. Melamed, D. Offen, 1997, Journal of neural transmission. Supplementum.

Novel molecular imaging of cell death in experimental cerebral stroke

A. Mayk, R. Djaldetti, I. Ziv, 2007, Brain Research.

Anti Sema3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy

A. Barzilai, I. Ziv, E. Melamed, 2002 .

Increased Plasma Endothelin‐1 in Acute Ischemic Stroke

A. Achiron, R. Djaldetti, I. Ziv, 1992, Stroke.

The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson's Disease

I. Ziv, E. Melamed, D. Offen, 2004, Apoptosis.

Dopamine-Induced Apoptosis Is Inhibited in PC12 Cells Expressing Bcl-2

I. Ziv, E. Melamed, D. Offen, 1997, Cellular and Molecular Neurobiology.

Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease?

I. Ziv, E. Melamed, D. Offen, 1997, Journal of neural transmission. Supplementum.

Oxidative stress and neuroprotection in Parkinson's disease: implications from studies on dopamine-induced apoptosis.

I. Ziv, E. Melamed, S. Gorodin, 1999, Advances in neurology.

ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis

I. Ziv, Galit Levin, S. Rosen, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Monoamine-Induced Apoptotic Neuronal Cell Death

A. Barzilai, I. Ziv, E. Melamed, 1997, Cellular and Molecular Neurobiology.

Relapsing myelitis

R. Djaldetti, I. Ziv, A. Achiron, 1992, Neurology.

Enhanced fatigue during motor performance in patients with Parkinson's disease

R. Djaldetti, I. Ziv, E. Melamed, 1998, Neurology.

Short-term beneficial effect of deprenyl monotherapy in early Parkinson's disease: a quantitative assessment.

R. Djaldetti, I. Ziv, E. Melamed, 1993, Clinical neuropharmacology.

From the Gla domain to a novel small-molecule detector of apoptosis

I. Ziv, Galit Levin, A. Shirvan, 2009, Cell Research.

From the Gla domain to a novel small-molecule detector of apoptosis

I. Ziv, Galit Levin, A. Shirvan, 2009, Cell Research.

Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase.

I. Ziv, E. Melamed, D. Offen, 2002, Journal of molecular neuroscience : MN.

Induction of mitosis-related genes during dopamine-triggered apoptosis in sympathetic neurons.

I. Ziv, E. Melamed, A. Barzilai, 1997, Journal of neural transmission. Supplementum.

Abstracts Second Congress of the European Society for Clinical Neuropharmacology

K. Jellinger, L. Iversen, K. Lesch, 1995, Journal of Neural Transmission / General Section JNT.

Apoptosis imaging with PET-18F-ML-10 for early assessment of response of brain metastases to radiotherapy

I. Ziv, A. Allen, E. Mishani, 2009 .

The molecular mechanisms of dopamine toxicity.

A. Barzilai, I. Ziv, E. Melamed, 2003, Advances in neurology.

Residual striatal dopaminergic nerve terminals in very long‐standing Parkinson's disease: A single photon emission computed tomography imaging study

R. Djaldetti, I. Ziv, E. Melamed, 2011, Movement disorders : official journal of the Movement Disorder Society.

18F-ML-10, a PET Tracer for Apoptosis: First Human Study

G. Antoni, B. Långström, I. Ziv, 2011, The Journal of Nuclear Medicine.

Molecular Imaging of Neurovascular Cell Death in Experimental Cerebral Stroke by PET

G. Antoni, I. Ziv, Galit Levin, 2008, Journal of Nuclear Medicine.

Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.

I. Ziv, E. Melamed, J. Zoldan, 1996, Advances in neurology.

Mutant and wild-type α-synuclein interact with mitochondrial cytochrome C oxidase

I. Ziv, E. Melamed, D. Offen, 2002, Journal of Molecular Neuroscience.

Aphasia in multiple sclerosis

A. Achiron, R. Djaldetti, I. Ziv, 1992, Neurology.

Molecular biology of dopamine-induced apoptosis : possible implications for Parkinson's disease.

I. Ziv, E. Melamed, D. Offen, 2001, Methods in molecular medicine.

Targeting cell death in vivo in experimental traumatic brain injury by a novel molecular probe.

I. Ziv, Galit Levin, E. Shohami, 2008, Journal of neurotrauma.

Gastric emptying in Parkinson's disease

R. Djaldetti, I. Ziv, E. Melamed, 1996, Neurology.

IL-3-LA production by mononuclear cells of patients with multiple sclerosis: effect of treatment with intravenous immunoglobulins.

R. Djaldetti, I. Ziv, E. Melamed, 1995, Immunological investigations.

Monitoring of Chemotherapy-Induced Cell Death in Melanoma Tumors by N,N′-Didansyl-L-cystine

I. Ziv, Galit Levin, A. Shirvan, 2007, Technology in cancer research & treatment.

Autoimmune polyendocrine syndrome type I and brain calcinosis.

R. Djaldetti, I. Ziv, D. Groshar, 2010, Parkinsonism & related disorders.

Spastic paraparesis associated with human T‐lymphotropic virus type I: A clinical, serological, and genomic study in Iranian‐born Mashhadi Jews

R. Djaldetti, I. Ziv, E. Melamed, 1993, Annals of neurology.

Primary progressive freezing gait

A. Achiron, I. Ziv, E. Melamed, 1993, Movement disorders : official journal of the Movement Disorder Society.

The Involvement of p53 in Dopamine-Induced Apoptosis of Cerebellar Granule Neurons and Leukemic Cells Overexpressing p53

A. Barzilai, I. Ziv, E. Melamed, 1999, Cellular and Molecular Neurobiology.

The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity.

A. Barzilai, I. Ziv, E. Melamed, 2000, Journal of neural transmission. Supplementum.

Effect of cisapride on response fluctuations in Parkinson's disease

A. Achiron, R. Djaldetti, I. Ziv, 1995, Movement disorders : official journal of the Movement Disorder Society.

Management of motor complications in advanced Parkinson's disease

R. Djaldetti, I. Ziv, E. Melamed, 2007, Movement disorders : official journal of the Movement Disorder Society.

Anti-semaphorin 3A Antibodies Rescue Retinal Ganglion Cells from Cell Death following Optic Nerve Axotomy*

A. Barzilai, I. Ziv, E. Melamed, 2002, The Journal of Biological Chemistry.

Intravenous immunoglobulin treatment in relapsing-remitting multiple sclerosis: A randomized, double-blind multicenter, placebo-controlled trial

A. Achiron, I. Ziv, U. Gabbay, 1995, Journal of Neuroimmunology.

Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis.

C. Gordon, A. Achiron, I. Ziv, 1992 .

Detection and measurement of an endogenous clonidine-displacing substance in human cerebrospinal fluid

R. Djaldetti, I. Ziv, E. Melamed, 1993, Brain Research.

Fatigue in multiple sclerosis compared with chronic fatigue syndrome

A Achiron, A. Achiron, R. Djaldetti, 1996, Neurology.

Editorial: apoptosis in the aging brain

I. Ziv, E. Melamed, 2010, Apoptosis.

Patient and caregiver perceptions of the social impact of advanced Parkinson’s disease and dyskinesias

R. Djaldetti, I. Ziv, E. Melamed, 2012, Journal of Neural Transmission.

Molecular imaging of neurodegeneration by a novel cross-disease biomarker

I. Ziv, A. Shirvan, A. Reshef, 2009, Experimental Neurology.

Semaphorins as Mediators of Neuronal Apoptosis

A. Barzilai, I. Ziv, E. Melamed, 1999, Journal of neurochemistry.

The Pharmacokinetic Profile of the “First Ever” Oral Dose of Levodopa in De Novo Patients with Parkinson's Disease

R. Djaldetti, I. Ziv, E. Melamed, 2001, Clinical neuropharmacology.

First emergence of “delayed‐on” and “dose failure” phenomena in a patient with Parkinson's disease following vagotomy

A. Achiron, R. Djaldetti, I. Ziv, 1994, Movement disorders : official journal of the Movement Disorder Society.

Diagnosis of “non-organic” limb paresis by a novel objective motor assessment: the quantitative Hoover’s test

R. Djaldetti, I. Ziv, E. Melamed, 1998, Journal of Neurology.

Role of apoptosis in the pathogenesis of Parkinson's disease: A novel therapeutic opportunity?

I. Ziv, E. Melamed, 1998, Movement disorders : official journal of the Movement Disorder Society.

Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action.

I. Cohen, A. Achiron, I. Ziv, 1994, Journal of neurology, neurosurgery, and psychiatry.

Lymphocyte ultrastructure in patients with multiple sclerosis.

R. Djaldetti, I. Ziv, A. Achiron, 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Induction of neuronal apoptosis by Semaphorin3A-derived peptide.

A. Barzilai, I. Ziv, E. Melamed, 2000, Brain research. Molecular brain research.

Open controlled therapeutic trial of intravenous immunoglobulins in relapsing-remitting multiple sclerosis

C. Gordon, I. Ziv, E. Melamed, 1991, Journal of Neuroimmunology.

123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Recurrent Sudden Falls: Are Such Falls a Distinct Entity?

R. Djaldetti, I. Ziv, E. Melamed, 2007, Journal of Nuclear Medicine Technology.

Involvement of T-complex Protein-1δ in Dopamine Triggered Apoptosis in Chick Embryo Sympathetic Neurons*

A. Barzilai, I. Ziv, E. Melamed, 2000, The Journal of Biological Chemistry.

Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned rats.

I. Ziv, E. Melamed, D. Offen, 2003, Pharmacology & toxicology.

Novel fluorescence molecular imaging of chemotherapy-induced intestinal apoptosis.

I. Ziv, Galit Levin, A. Shirvan, 2009, Journal of biomedical optics.